Interim data from NHLBI examining 3 international trials suggesting decreased morbidity and mortality for COVID-19 patients with therapeutic anticoagulation for patients not in the ICU. Please share this important summary. IT CAN SAVE LIVES.
Dear AVF Members,
We are delighted to share with you updated LCDs for the Medicare Administrative Contractors (MACs) First Coast and Novitas. These LCDs which are scheduled to take effect on 12/27/20, are felt to be very reasonable and appropriate concerning the care of our patients with venous disease. Through the prolonged efforts of the AVF Health Policy Committee, in conjunction with the SVS and the AVLS Health Policy Committee, we have LCDs that finally are appropriate for patients, providers, and payers. In the future, hopefully these will either translate to a National Coverage Determination (NCD), or similar LCDs with the other MACs. Thanks to all the current and past members of the AVF HPC, and our friends at SVS and AVLS for this achievement.
Harold J. Welch, MD – President, AVF
Mark D. Iafrati, MD – Chair, AVF Health Policy Committee
The AVF Health Policy Committee, in collaboration with the SVS and AVLS have been busy advocating for our patients and our members. This week, we submitted comment letters to CMS (Centers for Medicare and Medicaid Services) to address several significant regulatory issues. The first addresses a long-standing non-coverage decision regarding catheter based mechanical embolectomy for Pulmonary Embolism. The second addresses a proposed severe further reduction in the reimbursement for radiofrequency ablations over the next two years, based on an erroneous assumption about the prices we pay for RFA catheters. By raising our collective voices on these important issues, we hope push our agenda of educating the regulators and ensuring access to these vital services for our Medicare and Medicaid patients. Please take a moment to review these letters and feel free to add your voice with direct communication to your legislators in support of these important issues.
As you likely know, CMS has proposed a 7% cut in the Medicare payment rates scheduled to take effect January 1st, 2021. Multiple vascular societies are encouraging their members to contact their US Representative and US Senators to prevent these cuts, and the AVF is proud to be engaged in this effort. Please read the letter, and make your voice heard. Time is of the essence. Thank you.
Harold Welch, MD
The Journal of International Medical Research recently published “The 100 most-cited articles on chronic venous disease: a bibliometric analysis.”
The authors used bibliometric analysis to understand characteristics and trends in the research on chronic venous disease (CVD). They searched the Thomson Reuters Web of Science citation indexing database to identify the 100 most-cited manuscripts on CVD.
The resulting articles were analyzed by title, author, institution, topic, year of publication, and country of origin. They determined that the Journal of Vascular Surgery was the most cited.
You can read the entire article here: https://journals.sagepub.com/doi/full/10.1177/0300060520918711
The American Venous Forum is committed to increasing education and awareness of venous disease among healthcare professionals and promoting evidence-based best practices to ensure patients have access to the highest quality care. Creating and updating consensus clinical practice guidelines is essential to this mission.
The AVF has recently added new clinical practice guidelines to our website including Appropriate Use Criteria, Revised CEAP, and Compression Guidelines in both English and Spanish.